INIS
muscles
100%
diseases
78%
patients
71%
oxidation
37%
fibers
22%
inflammation
20%
control
19%
mitochondria
19%
lungs
18%
phenotype
17%
exercise
17%
proteins
17%
capacity
15%
levels
14%
regulations
14%
hypoxia
14%
losses
13%
metabolism
12%
receptors
11%
mice
10%
interventions
10%
comparative evaluations
9%
risks
8%
reviews
8%
fats
8%
performance
7%
kinases
7%
glycogen
6%
biopsy
6%
tobacco smokes
6%
Keyphrases
Chronic Obstructive Pulmonary Disease
61%
Skeletal muscle
35%
Oxidative Phenotype
16%
Chronic Obstructive Pulmonary Disease Patient
15%
COPD Patients
11%
Hypoxia
11%
Quadriceps
9%
Peroxisome Proliferator-activated Receptor
9%
Systemic Inflammation
9%
Quadriceps muscle
8%
Healthy Controls
8%
Nuclear factor-κB
8%
Tumor Necrosis Factor-α
7%
Mitochondrial Biogenesis
7%
Cachexia
6%
Muscle Wasting
6%
Muscle Fiber
6%
Muscle Mass
6%
Mitophagy
6%
Exercise Training
6%
Vastus Lateralis
6%
Fiber Type
6%
Myogenesis
6%
Sarcopenia
5%
Hypoxia-inducible factor-1α (HIF-1α)
5%
Oxidative Stress
5%
Glycogen Synthase kinase-3β (GSK-3β)
5%
Control Subjects
5%
Forced Expiratory Volume in 1 Second (FEV1)
5%
Coactivator
5%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
59%
Skeletal Muscle
27%
Hypoxia
9%
Exercise
9%
Muscle Atrophy
8%
Cachexia
5%
Sarcopenia
5%
